Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Efthymios N Deliargyris

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 12, 2017
Heparin or bivalirudin for non-primary PCI: Beware of neat and simple answers…Efthymios N Deliargyris, Carey Kimmelstiel
The American Journal of Cardiology|March 23, 2016
Trends in P2Y12 Inhibitor Use in Patients Referred for Invasive Evaluation of Coronary Artery Disease in Contemporary US PracticeWeihong Fan, Stephanie Plent, Jayne Prats, et al.
Seminars in Thrombosis and Hemostasis|July 30, 2004
Direct thrombin inhibitors in the treatment of immune-mediated heparin-induced thrombocytopeniaJason T Call, Efthymios N Deliargyris, David C Sane
Cardiology in Review|June 12, 2004
Focusing on inflammation in the treatment of atherosclerosisJason T Call, Efthymios N Deliargyris, L Kristin Newby
Critical Care Research and Practice|August 2, 2021
The Use of CytoSorb Therapy in Critically Ill COVID-19 Patients: Review of the Rationale and Current Clinical ExperiencesJuan Carlos Ruiz-Rodríguez, Zsolt Molnar, Efthymios N Deliargyris, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|July 17, 2007
Coronary artery disease following mediastinal irradiationSpyridon I Dragomanovits, George L Lazopoulos, Ioannis N Tzinieris, et al.
Journal of Cardiovascular Pharmacology|March 3, 2021
Influence of Lipid Excipients on Platelet Function and the Pharmacodynamic Effects of AspirinDavid J Schneider, Heidi S Taatjes-Sommer, Jayne Prats, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|July 17, 2007
Minimizing femoral access complications in patients undergoing percutaneous coronary interventions: a proposed strategy of bony landmark guided femoral access, routine access site angiography and appropriate use of closure devicesIoannis N Tzinieris, Georgios I Papaioannou, Spyridon I Dragomanovits, et al.
Seminars in Thrombosis and Hemostasis|July 30, 2004
Role of anti-PF4/heparin antibodies in recurrent thrombotic events after acute coronary syndromesMary Ann Mascelli, Efthymios N Deliargyris, Lakshmi V Damaraju, et al.
Journal of the American College of Cardiology|October 22, 2013
Reduction in cardiac mortality with bivalirudin in patients with and without major bleeding: The HORIZONS-AMI trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction)Gregg W Stone, Tim Clayton, Efthymios N Deliargyris, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 12, 2017
Heparin or bivalirudin for non-primary PCI: Beware of neat and simple answers…Efthymios N Deliargyris, Carey Kimmelstiel
The American Journal of Cardiology|March 23, 2016
Trends in P2Y12 Inhibitor Use in Patients Referred for Invasive Evaluation of Coronary Artery Disease in Contemporary US PracticeWeihong Fan, Stephanie Plent, Jayne Prats, et al.
Seminars in Thrombosis and Hemostasis|July 30, 2004
Direct thrombin inhibitors in the treatment of immune-mediated heparin-induced thrombocytopeniaJason T Call, Efthymios N Deliargyris, David C Sane
Cardiology in Review|June 12, 2004
Focusing on inflammation in the treatment of atherosclerosisJason T Call, Efthymios N Deliargyris, L Kristin Newby
Critical Care Research and Practice|August 2, 2021
The Use of CytoSorb Therapy in Critically Ill COVID-19 Patients: Review of the Rationale and Current Clinical ExperiencesJuan Carlos Ruiz-Rodríguez, Zsolt Molnar, Efthymios N Deliargyris, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|July 17, 2007
Coronary artery disease following mediastinal irradiationSpyridon I Dragomanovits, George L Lazopoulos, Ioannis N Tzinieris, et al.
Journal of Cardiovascular Pharmacology|March 3, 2021
Influence of Lipid Excipients on Platelet Function and the Pharmacodynamic Effects of AspirinDavid J Schneider, Heidi S Taatjes-Sommer, Jayne Prats, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|July 17, 2007
Minimizing femoral access complications in patients undergoing percutaneous coronary interventions: a proposed strategy of bony landmark guided femoral access, routine access site angiography and appropriate use of closure devicesIoannis N Tzinieris, Georgios I Papaioannou, Spyridon I Dragomanovits, et al.
Seminars in Thrombosis and Hemostasis|July 30, 2004
Role of anti-PF4/heparin antibodies in recurrent thrombotic events after acute coronary syndromesMary Ann Mascelli, Efthymios N Deliargyris, Lakshmi V Damaraju, et al.
Journal of the American College of Cardiology|October 22, 2013
Reduction in cardiac mortality with bivalirudin in patients with and without major bleeding: The HORIZONS-AMI trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction)Gregg W Stone, Tim Clayton, Efthymios N Deliargyris, et al.
Pageof 11